CLOPITAB 75 (Clopidogrel (75mg))

Clopitab 75 is classified as an antiplatelet agent, commonly referred to as a blood thinner. Its primary function is to prevent the development of dangerous blood clots within the circulatory system, thereby significantly reducing the likelihood of experiencing a heart attack or stroke. This medication is frequently prescribed to individuals identified as being at elevated risk for cardiovascular diseases, including those suffering from peripheral vascular disease, who have recently experienced a heart attack or stroke, those with arrhythmias, and individuals who have undergone specific cardiac interventions such as stenting. In certain scenarios, Clopitab may be used alongside other medications to address acute coronary events and various forms of cardiac-related chest pain, commonly described as unstable angina. The tablet can be ingested with or without food, but should ideally be taken consistently at the same time daily. It is crucial for patients to continue this treatment regimen, even if they are asymptomatic, as discontinuation could result in an increased risk of serious heart-related events. While the most frequently reported adverse effect is bleeding, which may manifest as bruising, nosebleeds, or the presence of blood in urine or stools, it is essential to seek medical advice if such bleeding becomes persistent or concerning. Clopitab is contraindicated in individuals who are experiencing bleeding complications, including those with stomach ulcers or intracranial hemorrhage. Prior to initiation, it is advisable to inform the healthcare provider of any history of clotting disorders or recent major injuries or surgeries, as this medication may need to be temporarily paused before elective surgical or dental procedures.